Monday, September 14, 2026

SOCIALISM’S FINAL FAILURE: Defector Economist Reveals Kim’s Regime Can’t Stop The Capitalist TAKEOVER

North Korean economist Seol Song Ah explores local economies in her book, highlighting shifts towards marketization and self-reliance.

ECB Warns: U.S. Stablecoins Could Shake Up Europe’s Financial System

ECB warns U.S. stablecoins could threaten EU financial sovereignty, urging reassessment of crypto regulations.

Rodri’s Golden Ball Triumph: How the Midfielder Led Spain to World Cup Glory

Rodri's silent strength led Spain to reclaim the top spot in football, earning him the Golden Ball at the 2026 FIFA World Cup.

Tag: drugs

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer Drug

Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.

Unlocking the Future: How Genomic Testing Enhances GLP-1 Obesity Treatment for Asian Patients

NGeneBio is developing tests to identify which patients benefit from GLP-1 weight loss drugs like Wegovy and Mounjaro, assessing side effects.

Bonjo Capsule: A Game-Changer for Severe Myelofibrosis Patients – Here’s Why

The South Korean MFDS has approved a rare drug, Vonjo Capsule (Pacritinib Citrate), for treating myelofibrosis.

AI-Powered Antibody Drug Development: Samsung Biologics and Protina’s Game-Changing License Agreement

Samsung Bioepis and Protina sign a licensing agreement to develop AI-designed antibody drugs, aiming for candidates by 2027.

Global Standards for Stimulant Drug Dependence: What You Need to Know

The world's first international standards for evaluating dependence on stimulant drugs are set to be established by the Ministry of Food and Drug Safety.

2026’s Game-Changer: Inventage Lab’s BioFluidic Technology Revolutionizes Antibody Drug Administration

Inventage Lab's CEO emphasizes the importance of platform technology for drug delivery systems and open innovation in the pharmaceutical industry.

Moxidectin vs. Traditional Heartworm Preventatives: Which Offers Better Protection in 2026?

Reports of drug resistance in heartworm prevention highlight the need for moxidectin-based strategies to combat ML-resistant strains.

Teen Prescriptions for GLP-1 Obesity Drugs Surge in Korea, Raising Misuse Concerns

Surge in GLP-1 obesity treatment prescriptions among teens raises concerns over misuse and potential health risks.

Mounjaro prescriptions surge 12-fold in 8 months, surpassing 200,000 monthly for the first time

Mounjaro prescriptions surged over tenfold in eight months, raising concerns about access for patients with obesity amid rising cosmetic demand.

44 Billion Won Drug Smuggling Case: How a Telegram Network Operated Illegal Pharmaceutical Sales

A South Korean drug gang has been indicted for selling $33 million in illegal pharmaceuticals, using messaging apps for distribution.

Samchundang Pharma CEO Claims FDA Recognition for Obesity Drug as Generic

Samchundang Pharma's CEO announces FDA recognition of oral semaglutide as a generic and withdraws $1.7 billion stock sale plan.

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

How Long-Term Use of Anticholinergic Medications Increases Fracture Risk by 65% in Seniors

A study reveals older adults on long-term medications face a 43% higher fracture risk, emphasizing the danger of anticholinergic drugs.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.